Cargando…
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Increased levels of low-density lipoprotein cholesterol (LDL-C) are recognized as a primary risk factor for atherosclerotic cardiovascular disease, which remains the leading cause of death worldwide. Lowering LDL-C levels clearly reduces the risk of cardiovascular events, with benefits related to bo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924077/ https://www.ncbi.nlm.nih.gov/pubmed/34514551 http://dx.doi.org/10.1007/s40256-021-00497-3 |